8-K
filed August 7, 2023, 7:59 PM ET
ticker WVE
CIK 0001631574
other material
confidence high
sentiment neutral
materiality 0.30
Wave Life Sciences shareholders approve 6.5M share increase to equity plan and 2M to ESPP
Wave Life Sciences Ltd.
- Shareholders approved amendment to 2021 Equity Incentive Plan adding 6,500,000 authorized shares.
- Shareholders approved amendment to 2019 ESPP adding 2,000,000 authorized shares.
- All nine director nominees re-elected; highest votes against were 9.3M for Ken Takanashi.
- KPMG reappointed as auditor (99.9% for); advisory say-on-pay approved with 98.5% of votes cast.
- Over 84% quorum; 83.5 million of 98.98 million shares voted at annual meeting.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Wave Life Sciences Ltd. shareholders approved Shareholders approved the Company’s payment of cash and equity-based compensation to the Company’s non-employee directors for their service on the Board of Directors and its committees at the 2023-08-01 meeting.
- Outcome
- passed
- Meeting
- 2023-08-01
Exact text from the filing
Shareholders approved the Company’s payment of cash and equity-based compensation to the Company’s non-employee directors for their service on the Board of Directors and its committees
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Wave Life Sciences Ltd. shareholders approved Shareholders approved the amendment to the Company’s 2019 Employee Share Purchase Plan at the 2023-08-01 meeting.
- Proposal
- equity plan
- Outcome
- passed
- Meeting
- 2023-08-01
Exact text from the filing
Shareholders approved the amendment to the Company’s 2019 Employee Share Purchase Plan
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Wave Life Sciences Ltd. shareholders approved Shareholders re-elected nine of the Company’s existing directors to the Board of Directors for a term ending on the Company’s 2024 Annual General Meeting of Shareholders and until his or her successor is duly elected and qualified at the 2023-08-01 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2023-08-01
Exact text from the filing
Shareholders re-elected nine of the Company’s existing directors to the Board of Directors for a term ending on the Company’s 2024 Annual General Meeting of Shareholders and until his or her successor is duly elected and qualified
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Wave Life Sciences Ltd. shareholders approved Shareholders approved the amendment to the Company’s 2021 Equity Incentive Plan, as amended at the 2023-08-01 meeting.
- Proposal
- equity plan
- Outcome
- passed
- Meeting
- 2023-08-01
Exact text from the filing
Shareholders approved the amendment to the Company’s 2021 Equity Incentive Plan, as amended
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Wave Life Sciences Ltd. shareholders approved Shareholders approved on a non-binding, advisory basis only, the compensation of the Company’s named executive officers at the 2023-08-01 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2023-08-01
Exact text from the filing
Shareholders approved on a non-binding, advisory basis only, the compensation of the Company’s named executive officers
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Wave Life Sciences Ltd. shareholders approved Shareholders approved the re-appointment of KPMG LLP to serve as the Company’s independent registered public accounting firm and independent Singapore auditor for the year ending December 31, 2023, and to authorize the Audit Committee of the Board of Directors to fix KPMG LLP’s remuneration for serv at the 2023-08-01 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2023-08-01
Exact text from the filing
Shareholders approved the re-appointment of KPMG LLP to serve as the Company’s independent registered public accounting firm and independent Singapore auditor for the year ending December 31, 2023, and to authorize the Audit Committee of the Board of Directors to fix KPMG LLP’s remuneration for services provided through the date of the Company’s 2024 Annual General Meeting of Shareholders
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Wave Life Sciences Ltd. shareholders approved Shareholders approved a general authorization for the directors of the Company to allot and issue ordinary shares of the Company at the 2023-08-01 meeting.
- Outcome
- passed
- Meeting
- 2023-08-01
Exact text from the filing
Shareholders approved a general authorization for the directors of the Company to allot and issue ordinary shares of the Company
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.